Pagsiat, Lenlen .

HRN: 28-46-97  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/26/2026
CO-AMOXICLAV 625MG (TAB)
01/26/2026
02/01/2026
PO
625mg
BID
Urinary Tract Infection
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Urinary Tract    Compliance to guidelines: